Table 4.
Effect of compounds 2–17 on HIV-1 RDDP and IN functions.
| Compound | IC50 (µM) |
|
|---|---|---|
| RDDP | IN | |
| 2 | >100 | 4.3 ± 1.5 |
| 3 | 60 ± 9 | 2.35 ± 0.44 |
| 4 | 57 ± 3 | 8.5 ± 0.3 |
| 5 | >100 | 6.5 ± 2.5 |
| 6 | 63 ± 11 | 89 ± 10 |
| 7 | 23.4 ± 0.5 | 31.5 ± 6.5 |
| 8 | 26.7 ± 2.2 | 3.4 ± 0.83 |
| 9 | 46 ± 3 | 7 ± 2 |
| 10 | 30.5 ± 0.4 | 3.4 ± 0.6 |
| 11 | >100 | 7.2 ± 0.7 |
| 12 | >100 | 6.61 ± 0.93 |
| 13 | 99 ± 1 | 23.18 ± 0.8 |
| 14 | >100 | >100 |
| 15 | 25.3 ± 6.3 | 5.35 ± 0.35 |
| 16 | 38 ± 4 | 0.69 ± 0.19 |
| 17 | 70 ± 1 | 1.44 ± 0.40 |
| EFV | 0.010 ± 0.005 | ND |
| RAL | ND | 0.055 ± 0.002 |